Kathryn F Lauderdale, APN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 4858 County Road 20, Geraldine, AL 35974 Phone: 256-659-2422 |
Michelle A Stuart, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 41263 Al Highway 75 Ste D, Geraldine, AL 35974 Phone: 256-659-2000 Fax: 256-659-2002 |
Lori Kristen Gorham Floyd, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 12062 Al Highway 227, Geraldine, AL 35974 Phone: 256-659-2422 |
News Archive
Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Novartis Pharmaceuticals Canada Inc. announced today that Lucentis (ranibizumab), the treatment for several major causes of vision loss, has been approved by Health Canada for the treatment of visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).
China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA").
› Verified 7 days ago